Stability indicating RP-HPLC method was developed for the simultaneous quantitation of Sofosbuvir and Velpatasvir in its pharmaceutical dosage form and validated. The drugs were separated on Discovery C18 (150mm x 4.6mm, 5µ) column using 0.01N potassium dihydrogen phosphate buffer and acetonitrile (50:50%v/v) as mobile phase on isocratic mode. The mobile phase is pump into the column at flow rate of 1.0ml/min and column oven temperature is maintained at 30ºC. The drugs were detected at a wavelength 240nm. The retention time for Sofosbuvir and Velpatasvir were found to be 2.32min and 3.34min respectively. The developed method is validated in accordance with ICH guidelines. The method was found to be accurate, precise, specific and robust. The method obeys Beer's law at a concentration range of 100µg/ml -600µg/ml of Sofosbuvir and 25µg/ml -150µg/ml of Velpatasvir, with correlation coefficient of 0.999 for both the drugs. The drugs were found to be stable and less prone to degradation when they are subjected to various stress conditions.
. The literature survey reveals that there is only one method i.e., RP-HPLC method [5] was developed for the simultaneous estimation of Sofosbuvir and Velpatasvir in pharmaceutical dosage from. The present study aimed to develop and validate a stability indicating method for the simultaneous determination of Sofosbuvir and Velpatasvir in the pharmaceutical dosage form using RP-HPLC. Average weight was calculated for 20 tablets (Velpanat) and an amount equivalent to 40mg of Sofosbuvir was taken into 10mL volumetric flask. The sample was dissolved in 10mL of diluent. The above solution was filtered using HPLC filters. Pipette out 1mL of the above solution into 10mL volumetric flask and made up with diluent.
Method Validation
The developed method was validated in accordance with ICH guidelines [6] . System suitability: Inject standard solution into the chromatographic system and calculate the parameters such as % relative standard deviation (RSD), tailing factor, plate count and resolution. Linearity: Serial dilutions of standard Sofosbuvir and Velpatasvir in the range of 100µg/mL -600µg/mL and 25µg/mL -150µg/mL respectively were prepared and injected into the HPLC. A linearity graph was plotted between concentration and peak areas. , neutral (refluxingthedrugsinwaterfor6hrsatatemperature of 60ºC), photolytic (exposing the drugs solution to UV light by keeping the beaker in UV Chamber for 7 days or 200Watt hours/m 2 in photo stability chamber) and thermal (drugs solution was placed in an oven at 105ºC for 6 hours) conditions.
Results and Discussion
Initially various mobile phases and columns were tried to elute the drugs. Discovery C18 (150mm x 4.6mm, 5µ) column, mobile phase consisting of 0.01N Potassium dihydrogen phosphate and Acetonitrile (50:50) on isocratic mode at flow rate 1.0ml/min was used to separate the drugs. The detection wavelength was selected from the overlay UV spectrum and was found to be 240nm as shown in Figure 2 . : Linearity plot of Velpatasvir The % RSD was found to be 0.3 for Sofosbuvir and 0.8 for Velpatasvir and % recovery was found to be 99.58% -100.13% for Sofosbuvir and 99.80% -100.45% for Velpatasvir, indicating the method to be accurate and precise. The method was found to berugged, robust and stable up to 24 hours. The developed method was found to be specific for the drugs, as there is no interference of placebo peaks with the retention time of drugs. The placebo chromatogram was shown in figure 7.The system suitability parameters and validation parameters results are summarized in table 1. 6.8 The forced degradation studies were conducted by exposing the standard solution to the various stress conditions. The net degradation was found to be within the limits, indicates that the drugs are stable at various stress conditions. The forced degradation studies results were summarized in table 2 and chromatograms were shown in figure 8. Stability indicating RP-HPLC method was developed for the simultaneous estimation of Sofosbuvir and Velpatasvir in pharmaceutical dosage form. The developed method was validated and found to be specific, accurate, precise, linear and robust. The drugs, Sofosbuvir and Velpatasvir were stable under different forced degradation conditions. The developed method can be used for the rapid quantification of Sofosbuvir and Velpatasvir in its pharmaceutical dosage form.
